Dong-er Zhang

Title(s)	Professor, Pathology
School	Vc-health Sciences-schools
Address	9500 Gilman Drive # La Jolla CA 92093
vCard	Download vCard

Research

Research Activities and Funding

USP18 in Cancer Development
NIH R01CA232147Apr 1, 2019 - Mar 31, 2024
Role: Principal Investigator

CSF2 receptor mediated actions in t(8;21) leukemia
NIH R01CA192924Feb 13, 2015 - Jan 31, 2020
Role: Principal Investigator

Synergestic roles of SRF2 and RUNX1 in blood cell development and pathology
NIH R01DK098808Sep 16, 2013 - Apr 30, 2023
Role: Principal Investigator

Synergestic roles of SRF2 and RUNX1 in blood cell development and pathology
NIH R56DK098808Sep 16, 2013 - Apr 30, 2019
Role: Principal Investigator

ISG15 and Protein ISGylation in Cancer
NIH R01CA177305Mar 1, 2013 - Feb 29, 2024
Role: Principal Investigator

International RUNX Workshop
NIH R13CA159538Jul 1, 2011 - Dec 31, 2011
Role: Principal Investigator

Cancer Researchers in Nanotechnology (CRIN)
NIH T32CA153915Sep 3, 2010 - Apr 30, 2022
Role: Principal Investigator

UBP43 in Hematopoiesis
NIH R01HL091549Sep 15, 2008 - Aug 31, 2015
Role: Principal Investigator

FASEB Conference-Hematological Malignancies
NIH R13CA117424Jul 22, 2005 - Jun 30, 2010
Role: Principal Investigator

Mechanism of Interferon Response and Resistance in CML
NIH R01CA102625Jul 16, 2004 - Jun 30, 2009
Role: Principal Investigator

Molecular Mechanism of Leukemogenesis involving AML1-ETO
NIH R01CA104509Dec 1, 2003 - Mar 31, 2026
Role: Principal Investigator

Role of Ubiquitin Like Protein ISG15 Conjugation
NIH R01GM066955Dec 1, 2002 - Jun 30, 2012
Role: Principal Investigator

t(8;21) and SON in Blood Cell Proliferation and Differentiation
NIH R01CA096735Jul 1, 2002 - Nov 30, 2014
Role: Principal Investigator

UBP43 in Hematopoiesis
NIH R01CA079849Oct 25, 1999 - Mar 31, 2009
Role: Principal Investigator

INTERACTING FACTORS IN HEMATOPOIESIS AND LEUKEMIA
NIH P01CA072009Sep 15, 1997 - Apr 30, 2008
Role: Co-Investigator

Comprehensive Biology: Exploiting the Yeast Genome
NIH P41RR011823Sep 30, 1996 - Jun 30, 2016
Role: Co-Investigator

CD14 REGULATION BY MONOCYTE DIFFERENTIATION &CYTOKINES
NIH R29CA059589Jul 1, 1994 - Jun 30, 2000
Role: Principal Investigator

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Type I Interferon Regulates a Coordinated Gene Network to Enhance Cytotoxic T Cell-Mediated Tumor Killing. Cancer Discov. 2020 03; 10(3):382-393. Fan JB, Miyauchi S, Xu HZ, Liu D, Kim LJY, Burkart C, Cheng H, Arimoto KI, Yan M, Zhou Y, Gyorffy B, Knobeloch KP, Rich JN, Cang H, Fu XD, Zhang DE. PMID: 31974171; PMCID: PMC7058499.

View in: PubMed Mentions: 20 Fields:
Neo Neoplasms
Translation:Humans Animals Cells
Plakophilin-2 promotes tumor development by enhancing ligand-dependent and -independent epidermal growth factor receptor dimerization and activation. Mol Cell Biol. 2014 Oct; 34(20):3843-54. Arimoto K, Burkart C, Yan M, Ran D, Weng S, Zhang DE. PMID: 25113560; PMCID: PMC4187709.

View in: PubMed Mentions: 26 Fields:
Cel Cell Biology Mol Molecular Biology
Translation:Humans Animals Cells